Published November 1, 2021 at 5:12pm
A new international report of 64 studies shows Ivermectin has an 86% success rate as a prophylaxis and a 67% success rate in early treatment of coronavirus.
The results mirror the over 290 studies on hydroxychloroquine that have been reported over the past year.
The Gateway Pundit has reported extensively on the CDC’s decisions that resulted in the deaths of thousands of Americans.
The new international report shows Ivermectin does extremely well as a prophylaxis and in mortality results.
And Ivermectin performs better than other medications.
Here is the entire study for you to peruse.
The Gateway Pundit is always committed to ensuring your voice can and will be heard. To reinforce that commitment, we are switching our commenting platform to Insticator. Don’t worry! All you have to do is create a commenting account with Insticator, and then you will be able to link past comments into your new Insticator account. For more information, we’ve written an article that you can read HERE. If you have any feedback or questions about your Insticator commenting account, please email them at: commenting-help@insticator.com.
0 Comments